ClinVar Miner

Submissions for variant NM_000518.4(HBB):c.374C>G (p.Pro125Arg) (rs33983276)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Integrated Genetics/Laboratory Corporation of America RCV000780333 SCV000917504 likely pathogenic Hemoglobinopathy 2018-12-20 criteria provided, single submitter clinical testing Variant summary: HBB c.374C>G (p.Pro125Arg) results in a non-conservative amino acid change in the encoded protein sequence. The variant is also reported in the literature as Hb Khartoum. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 246070 control chromosomes (gnomAD). c.374C>G has been reported in the literature in a Sudanese family, together with potentially pathogenic variants in the A-gamma (HBG1) and G-gamma (HBG2) genes, in 2 newborns who were affected with severe neonatal jaundice at birth and chronic mild hemolytic anemia during the first year of life, and the variant showed complete segregation with the disease (Bayoumi 1999). Heterozygous carriers in this family had no major hematological phenotypes (Bayoumi 1999), in addition the variant was also reported in a Vietnamese heterozygous carrier, in whom all hematological values were within the normal range (Hendy 1999); these reports suggest that Hb Khartoum alone does not seem to cause any clinical or hematological abnormalities. At least one publication reported experimental evidence and demonstrated only minor changes in protein stability, concluding that the variant protein is probably not unstable in vivo, however no further functional studies (e.g. for oxygen binding properties) were performed (Clegg 1969). Other variants at the same nucleotide position have been reported as associated with disease (c.374C>A, c.374C>T in HGMD), as well as in adjacent codons (e.g. p.T124I and p.V127E), all of which support a pathogenic role for the variant. Several reputable databases have classified the variant as a causative variant (e.g. HbVar and Ithanet). Overall, these data indicate that the variant is likely to be associated with disease. Based on the evidence outlined above, the variant was classified as likely pathogenic.
OMIM RCV000016438 SCV000036706 other HEMOGLOBIN KHARTOUM 2017-12-12 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.